A Study of IBI3003 in People With Multiple Myeloma

Full Title

A Phase I/II, Multicenter, Open-label Study of IBI3003 in Participants with Relapsed or Refractory Multiple Myeloma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Carlyn Rose Tan’s office at 646-608-3778.

Protocol
26-205
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Relapsed or Refractory
Investigator
Carlyn Rose Tan
Co-Investigators
Saad Z. Usmani
Diseases
Hematology › Multiple Myeloma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06083207
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description